We use cookies and analytics tools to improve the user experience on the Internet site and for marketing purposes. If you continue to use this site, we will assume that you agree. To the privacy policy.
Treats and limits the recurrence of eczema lesions
Dexyane Med Cream for face, body and hands. Medical device* for the treatment of atopic dermatitis and contact eczema, promotes healing and limits recurrence. Relieves itching and reduces the intensity of inflammatory signs in eczema on the body, face and hands. Alone, in combination with and/or after dermocorticosteroids.
Benefits:
Relieves itching.
Treats eczema lesions.
Limits the recurrence of eczema lesions.
*Dexyane Med Cream for face, body and hands is a medical device that meets the legal requirements of the EU Medical Device Regulation and is therefore marked with the CE mark. Please read the instructions in the package leaflet carefully. Do not use during pregnancy or breastfeeding, on mucous membranes or in the diaper area of infants. Avoid direct contact with the eyes. From the age of 3 months.
Expert advice by a pharmacist: info@haar-shop.ch / 033 550 30 30 (Mon – Fri | 08:00 – 18:00)
Product characteristics
Brand
Ducray
Ingredients
Glycerin
Care
calmingdermatologically testedregenerating
Skin type
sensitivedry
How to use
Apply directly to the inflammatory eczema lesions twice daily.
Use alone, in combination with, and/or after dermocorticoids.
When using in combination with a dermocorticoid, apply the dermocorticoid and wait a few minutes (5–15 minutes) before applying Dexyane Med cream.
Do not use if you are allergic to any of the ingredients.
Consult a doctor in case of allergic reactions.
Avoid contact with the eyes to prevent irritation.
If contact with the eyes occurs, rinse immediately with clear water.
If eye irritation persists, consult a doctor.
Do not use during pregnancy or while breastfeeding.
Keep out of reach of children.
Do not apply in the diaper area or on mucous membranes.
Do not treat more than 30% of the body surface area.
Close the tube tightly after use.
Skin reactions at the application site (skin burning, tingling, erythema, itching, dryness...) are to be expected in patients with eczema due to a compromised skin barrier. There may be a temporary worsening of the eczema. If there is no improvement or if eczema symptoms worsen within 8–10 days, a doctor should be consulted.
If you have reason to believe that a serious incident related to the use of the medical device has occurred, please report it to the relevant national authority and the manufacturer.
https://www.haar-shop.ch/en/60079911-1-dexyane-med-creme.html?___store=en83211Dexyane Med Creamhttps://cdn.haarshop.ch/catalog/product/thumbnail/0fff26e41e2ff3cd52165a5782077c1283555a8aa490530f91d7b5c9/small_image/0/448x448/001/99/4/6/468c569f0e20654a6438860abd7085bd0e0b6d74_3282770394207_bi_ducray_dexyane_creme_30_2.jpg26.926.9CHFInStock/Brands/Care/Care/Body care/Care/Body care/Body lotion/Dermatology/Dermatology/Body/Dermatology/Body/Body lotion/Brands/Ducray29189990992270027022715550212189990270027029<p><strong>Treats and limits the recurrence of eczema lesions</strong></p>
<p>Dexyane Med Cream for face, body and hands. Medical device* for the treatment of <strong>atopic dermatitis</strong> and <strong>contact eczema</strong>, promotes healing and <strong>limits recurrence</strong>. <strong>Relieves itching</strong> and reduces the intensity of inflammatory signs in eczema on the body, face and hands. Alone, in combination with and/or after dermocorticosteroids.</p>
<p><br></p>
<p><strong>Benefits:</strong></p>
<ul>
<li>Relieves itching.</li>
<li>Treats eczema lesions.</li>
<li>Limits the recurrence of eczema lesions.</li>
</ul>
<p><br></p><p><br></p>
<p><em>*Dexyane Med Cream for face, body and hands is a medical device that meets the legal requirements of the EU Medical Device Regulation and is therefore marked with the CE mark. Please read the instructions in the package leaflet carefully. Do not use during pregnancy or breastfeeding, on mucous membranes or in the diaper area of infants. Avoid direct contact with the eyes. From the age of 3 months.</em></p><div><br></div><div><img src="data:image/png;base64,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" data-filename="download.png" style="width: 33px;"> <strong>Expert advice by a pharmacist:<a href="mailto:%20info@haar-shop.ch" target="_blank"> info@haar-shop.ch</a> / 033 550 30 30</strong> (Mon – Fri | 08:00 – 18:00)<br></div>DucrayCHF00https://cdn.haarshop.ch/catalog/product/e/3/e3535dd270ea9f66d9dda9e61ae24c8977d14158_3282770394207_ai_ducray_dexyane_creme_30_1.jpgsku:60079911-1not_in_nosto:Nodd_deal:dd_items:0dd_from:dd_initialAmount:dd_to:dd_price:dd_displayType:badge_counter82918Dexyane Med Cream26.926.9https://cdn.haarshop.ch/catalog/product/4/6/468c569f0e20654a6438860abd7085bd0e0b6d74_3282770394207_bi_ducray_dexyane_creme_30_2.jpgInStock30 ml82917Dexyane Med Cream36.936.9https://cdn.haarshop.ch/catalog/product/3/0/303d89e0771484f8ff187873ed54f63cf9225e9f_3282770394238_bi_ducray_dexyane_med_creme.jpgInStock100 mlhttps://cdn.haarshop.ch/catalog/product/thumbnail/75d88ba1fcf3cb58909d5e87b2f53d4ee0773273cb8bc11d56167f3d/small_image/0/224x224/001/99/4/6/468c569f0e20654a6438860abd7085bd0e0b6d74_3282770394207_bi_ducray_dexyane_creme_30_2.jpgNo60079911-1Cream, Hand cream, Body creamDexyane Med CreamDucrayNoNosensitive, drycalming, dermatologically tested, regeneratingGlycerin2024-12-04 00:00:002025-02-04 00:00:00NoYesconfigurable
We ship with
Payment
Invoice
Cash in advance
Responsibility
Compensated CO2 emission by haar-shop.ch: 1'100'000 kg